- Home
- PRVA vs BHC Comparison
PRVA vs BHC Comparison
Compare PRVA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- BHC
- Stock Information
- Founded
- PRVA 2007
- BHC N/A
- Country
- PRVA United States
- BHC Canada
- Employees
- PRVA N/A
- BHC N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- PRVA Technology
- BHC Health Care
- Exchange
- PRVA Nasdaq
- BHC Nasdaq
- Market Cap
- PRVA 2.7B
- BHC 2.3B
- IPO Year
- PRVA 2021
- BHC N/A
- Fundamental
- Price
- PRVA $20.58
- BHC $6.45
- Analyst Decision
- PRVA Strong Buy
- BHC Hold
- Analyst Count
- PRVA 14
- BHC 4
- Target Price
- PRVA $28.50
- BHC $7.00
- AVG Volume (30 Days)
- PRVA 1.1M
- BHC 2.1M
- Earning Date
- PRVA 08-07-2025
- BHC 07-30-2025
- Dividend Yield
- PRVA N/A
- BHC N/A
- EPS Growth
- PRVA N/A
- BHC N/A
- EPS
- PRVA 0.12
- BHC N/A
- Revenue
- PRVA $1,801,244,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- PRVA $90.45
- BHC $3.71
- Revenue Next Year
- PRVA $10.52
- BHC $5.03
- P/E Ratio
- PRVA $171.90
- BHC N/A
- Revenue Growth
- PRVA 6.79
- BHC 8.53
- 52 Week Low
- PRVA $16.47
- BHC $3.96
- 52 Week High
- PRVA $26.09
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- PRVA 35.44
- BHC 57.81
- Support Level
- PRVA $20.39
- BHC $6.23
- Resistance Level
- PRVA $21.24
- BHC $7.24
- Average True Range (ATR)
- PRVA 0.67
- BHC 0.26
- MACD
- PRVA -0.10
- BHC -0.09
- Stochastic Oscillator
- PRVA 8.05
- BHC 21.29
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.